Related Experiment Video
Updated: Sep 5, 2025
12:44
Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
3.9K
Drug Screening Implicates Chondroitin Sulfate as a Potential Longevity Pill
1Laboratory of Extracellular Matrix Regeneration, Department of Health Sciences and Technology, Institute of Translational Medicine, ETH Zürich, Switzerland.
Frontiers in Aging
|July 13, 2022
Summary
Chondroitin sulfate, a naturally occurring compound, shows promise as a geroprotector. Supplementation may slow aging and prevent age-related diseases by maintaining extracellular matrix and reducing inflammation.
Area of Science:
- Biogerontology
- Molecular Biology
- Biochemistry
Background:
- Discovering geroprotectors is crucial for mitigating age-related diseases.
- Chondroitin sulfate (CS) is a glycosaminoglycan with demonstrated geroprotective potential in silico and model organisms.
- CS is naturally produced, orally tolerated, and shows positive correlations with human longevity.
Purpose of the Study:
- To review the potential mechanisms of chondroitin sulfate as a geroprotective strategy.
- To highlight CS's role in counteracting age-related pathologies.
- To discuss CS's potential for promoting healthy human aging.
Main Methods:
- In silico and model organism lifespan screens identified CS as a geroprotector.
- Review of existing literature on CS pharmacokinetics, human longevity correlations, and clinical trial data.
- Analysis of proposed mechanisms: extracellular matrix homeostasis and inflammation inhibition.
Main Results:
- Chondroitin sulfate supplementation extended lifespan in C. elegans.
- Oral CS exhibits favorable pharmacokinetics and high tolerance in humans.
- Clinical trials suggest CS efficacy in decelerating age-related diseases.
Conclusions:
- Chondroitin sulfate demonstrates significant potential as a geroprotective strategy for promoting healthy aging.
- Mechanisms include maintaining extracellular matrix integrity and inhibiting inflammation.
- Further research into CS supplementation could lead to novel interventions for age-related conditions.
